___

• Akar N, Hasipek M, Akar E. Serum amyloid A1 and tumor nec- rosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid 2003; 10:12-16.
• Ben-Chetrit E, Levy M. Familial Mediterranean Fever. Lancet 1998; 351: 659-667.
• Ben-Chetrit E. Familial Mediterranean Fever (FMF) and renal AA amyloidosis-phenotype-genotype correlations, treatment and prognosis. J Nephrol 2003; 16: 431-438.
• Ben-Cheritt E, Backenroth R. Amyloidosis induced, end stage re- nal diseasein patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis 2001; 60: 146-149.
• Blum A, Sohar E. The diagnosis of amyloidosis.Ancillary proce- dures. Lancet 1962; 1: 721-724.
• Brik R, Shinawi M, Kepten I. Familial Mediterranean fever: cli- nical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999; 103: 70-76.
• Cazeneuve C, Sarkisian T, Pecheux C. MEFV-gene analysis in Armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygo- us genotype-genetic and therapeutic implications. Am J Hum Ge- net 1999; 65:88-97.
• Dagan T, Danon Y, Lotan R. Phenotype-genotype in FMF: Fami- lial Mediterranean Fever. The official book of 1 st International Conference on FMF, September 1997; 239-245.
• Duzova A, Bakkaloglu A, Besbas N. Role of A-SAA in monito- ring subclinical inflammation and in colchicine dosage in famili- al Mediterranean fever. Clin Exp Rheumatol 2003; 21: 509-514.
• Gershoni-Baruch R, Brik R, Shinawi M. The differential contri- bution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002; 10: 145-149.
• Gershoni-Baruch R, Brik R, Zacks N. The contribution of ge- notypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003; 48: 1149-1155.
• Goldfinger SE. Colchicine for familial Mediterranean fever. N Engl J Med 1972; 287: 1302.
• Korkmaz C, Ozdogan H, Kasapcopur O. Acute phase response in familial Mediterranean fever. Ann Rheum Dis 2002; 61:79-81.
• Lidar M, Yaqubov M, Zaks N. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 2006; 33: 1089-1094.
• Livneh A, Shtrasburg S, Langevitz P. Regression of nephrotic syndrome in amyloidosis of familial Mediterranean fever follo- wing colchicine treatment. Nephrol Dial Transplant 2000; 15:1713-1714.
• Majeed HA, El-Shanti H, Al-Khateeb MS. Genotype/phenotype correlations in Arab patients with familial Mediterranean fever. Semin Arthritis Rheum 2002; 31:371-376.
• Mansour I, Delague V, Cazeneuve C. Familial Meditarranean fe- ver in Lebanon: mutation spectrum, evidence cases in Maronites, Greek Orthodoxes, Greek Catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M691 mu- tations. Eur J Hum Genet 2001; 9: 51-55.
• Minetti EE, Minetti L. Multiple organ failure in a kidney transp- lant patient receiving both colchine and cyclosporine. J Nephrol 2003; 16: 421-425.
• Ozdogan H, Arısoy N, Kasapcapur O, Sever L, Calıskan S, Tu- zuner N, Mat C, Yazıcı H. Vasculitis in familial Mediterranean fe- ver. J Rheumatol 1997; 24: 323-327.
• Ozen S, Karaaslan Y, Ozdemir O. Prevalance of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 1998; 25: 2445-2449.
• Pras E, Aksentijevich I, Gruberg L. Maping of a gene causing fa- milial Mediterranean fever to the short of chromosome 16. N Engl J Med 1992; 326: 1507-1509.
• Pras E, Livneh A, Balow JE. Clinical differences between north African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998; 75: 216-219.
• Rubinger D, Friedlaender MM, Popovtzer MM. Amelioration of familial Mediterranean fever during hemodialysis. N Engl J Med 1979; 301: 142-144.
• Saatcı U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topalog- lu R, Arslan S. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 1997; 156: 619-623.
• Said R, Hamzeh Y, Tarawneh M, el-Khateeb M, Abdeen M, Sha- heen A. Rapid progressive glomerulonephritis in patients with fa- milial Mediterranean fever. Am J Kidney Dis 1989; 14: 412-416.
• Shonat M, Danon YL, Rotter JI. Familial Mediterranean fever: Analysis of inheritance and current linkage data. Am J Med Ge- net 1992; 44: 183-188.
• Shonat M, Livneeh A, Zemer D. Twin studies in familial Medi- terranean fever. Am J Med Genet 1992; 44: 179-186.
• Sidi G, Shinar Y, Livneh A. Protracted febrile myalgia of famili- al Mediterranean fever. Mutation analysis and clinical correlati- ons. Scand J Rheumatol 2000; 29: 174-176.
• Sohar E, Gafni J, Pras M. Familial Mediterranean fever a survey of 470 cases and review of the literature. Am J Med 1967; 43: 227-253.
• Tekin M, Yalcınkaya F, Cakar N. MEFV mutations in multiplex families with familial Mediterranean fever. is a particular genoty- pe necessary for amyloidosis? Clin Genet 2000; 57: 430-434.
• Tekin M, Yalcınkaya F, Tumer N, Cakar N, Kocak H, Ozkaya N, Gencgonul H. Familial Mediterranean fever- renal involvement by diseases other than amyloid. Nephrol Dial Transplant 1999; 14: 475-479.
• The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause fa- milial Mediterranean fever. Cell 1997; 90: 797-807.
• The French FMF Consortium. A candidate gene for familial Me- diterranean fever. Nat Genet 1997; 17: 25-31.
• Tidow N, Chen X, Muller C. Hematopoietic- specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood 2000; 95: 1451-1459.
• Tishler M, Pras M, Yaron M. Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever. Clin Exp Rheuma- tol 1988; 6: 395-397.
• Touitou I, Picot M-C, Domingo C. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001; 44: 163-169.
• Turkmen A, Yıldız A, Erkoc R. Transplantation in renal amylo- idosis. Clin Transplant 1998; 12: 375-378.
• Yalcınkaya F, Tekin M, Cakar N. Familial Mediterranean fever and systemic amyloidosis in untreated Turkish patients. Q J Med 2000; 93: 681-684.
• Yalcınkaya F, Tumer N. Glomerular lesions other than amyloido- sis in patients with familial Mediterranean fever. Nephrol Dial Transplant 1999; 14: 21-23.
• Yıldız A, Akkaya V, Kılıcaslan R. Cardiac and intestinal amylo- idosis in a renal transplant recipient with familial Mediterranean fever. J Nephrol 2001; 14: 125-127.
• Zemer D, Livneh A, Danon YL, Pras M, Sohar E. Long-term colchicine treatment in children with familial Mediterranean fe- ver. Arthritis Rheum 1991; 34: 973-977.
• Zemer D, Pras M, Sohar E. Colchicine in the prevention and tre- atment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 2001-2005.